Please login to the form below

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK

This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges.

We know that people from ethnic minorities are underrepresented in clinical trials.

Put simply, underrepresentation of anyone - male or female, old or young, and any ethnicities - means that researchers don’t actually know if the treatment or drug they’re investigating works for everyone. And that’s not okay.

People’s genetic make ups are all different. So, if we don’t know how everyone reacts to drugs or treatments, we don’t know if, at best they work, or at worst they have detrimental effects. We have to ask ourselves, is that ethical?

But what can we do to overcome it? Firstly, we must increase our understanding of why this is such a big issue. Here at COUCH Health, we set out to delve into the reasons why study populations are not diverse, and the barriers faced by different ethnic groups.

The research report engaging different faith based and minority groups has thrown up some interesting discussion points.

Download the report here.


  Demand Diversity Report
PDF File: 1.6 MB

25th May 2020


  Demand Diversity Report
PDF File: 1.6 MB



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

Whats the difference between patient engagement and patient experience?
We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same. So, let’s quickly clear up once and for all what the difference between patient engagement and patient experience is, so we can make sure that we’re doing the best possible job in both areas…
COUCH Health
Building trust in clinical trials whilst it is in the public eye
We’re all well aware that healthcare organisations are generally perceived to be untrustworthy. According to Edelman’s 2018 Trust Barometer, we even saw a clear global decline of public trust in pharma, biotech, hospitals, insurance and consumer health companies.
COUCH Health
Diversity in clinical trials needs to extend beyond COVID-19 vaccine trails
First up, the hard truth is that clinical trial populations are not diverse. People of certain ethnicities, females and the elderly are typically underrepresented in clinical research. And you might ask, “why?”
COUCH Health
Insights from patients during the COVID-19 pandemic
We all know how much the COVID-19 pandemic has affected everyone around the world. And within the healthcare industry, priorities have been re-evaluated and processes changed, to ensure that patients keep receiving care.
COUCH Health
September 2020: diversity and inclusion in clinical trials round-up
Our latest round-up takes a closer look at the different conditions where health disparities are present, such as more women living with multiple sclerosis (MS), and the cancer death rate being highest among Black people vs all other ethnic groups. Plus, there are a couple of articles with important insights about inequalities in LGBTQ+ communities, too.
COUCH Health
Why Facebook is not the solution to inclusive patient recruitment
With so many clinical trials underway to find an effective vaccine for COVID-19, the competition is rising. More and more organisations will be looking to recruit healthy volunteers, while ensuring inclusion and diversity in clinical trials, to complete their mission of finding a vaccine and making it available to the public as quickly as possible.
COUCH Health